Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration – evaluation in a clinical setting

BACKGROUND: To identify risk factors for being a “reduced responder” to ranibizumab treatment in a clinical setting in patients with neovascular age-related macular degeneration. METHODS: This retrospective study included 165 eyes of 165 consecutive patients with choroidal neovascularisation seconda...

Descripción completa

Detalles Bibliográficos
Autores principales: Korb, Christina, Zwiener, Isabella, Lorenz, Katrin, Mirshahi, Alireza, Pfeiffer, Norbert, Stoffelns, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878195/
https://www.ncbi.nlm.nih.gov/pubmed/24359591
http://dx.doi.org/10.1186/1471-2415-13-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878195/
https://www.ncbi.nlm.nih.gov/pubmed/24359591
http://dx.doi.org/10.1186/1471-2415-13-84

Ejemplares similares